Rashed Dewan
Directeur Financier/CFO chez PROFOUND MEDICAL CORP.
Fortune : 175 015 $ au 31/05/2024
Profil
Rashed Dewan is currently working as the Chief Financial Officer at Profound Medical Corp.
He started this position in 2022.
Previously, he worked as a Controller at Profound Medical, Inc. Mr. Dewan completed his undergraduate degree at the University of Southern California.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PROFOUND MEDICAL CORP
0,10% | 15/08/2023 | 23 747 ( 0,10% ) | 175 015 $ | 31/05/2024 |
Postes actifs de Rashed Dewan
| Sociétés | Poste | Début |
|---|---|---|
| PROFOUND MEDICAL CORP. | Directeur Financier/CFO | 03/03/2022 |
Anciens postes connus de Rashed Dewan
| Sociétés | Poste | Fin |
|---|---|---|
Profound Medical, Inc.
 Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Comptroller/Controller/Auditor | - |
Formation de Rashed Dewan
| University of Southern California | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PROFOUND MEDICAL CORP. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Health Technology |
